Genetic Clues for Skin Cancer Therapies Flushing NY

Scientists have isolated a group of genetic mutations involved in the growth of melanoma, the deadliest form of skin cancer. Their work may lead to therapies with existing drugs that target the same mutations. Led by Yardena Samuels of the National Human Genome Research Institute, the research team from the U.S. National Institutes of Health (NIH) sequenced the protein tyrosine kinase (PTK) gene family in tumor and blood samples from people with metastatic melanoma.

Local Companies

Joseph Guerra
(201) 656-5263
3285 John F Kennedy Blvd
Jersey City, NJ
Martha Maso
(201) 666-9550
390 Old Hook Rd
Westwood, NJ
Arielle N B Kauvar
(212) 686-7306
317 E 34Th St # 11N
New York, NY
Paul Brody
(718) 894-5888
7305 Metropolitan Ave
Flushing, NY
Barry Pomerantz
(516) 889-2077
724 E Park Ave
Long Beach, NY
Edward Luka
(973) 478-2733
22 Shaw St
Garfield, NJ
Kuljit Chima
(201) 692-0800
130 Kinderkamack Road
River Edge, NJ
Laura Buccheri-Zappi
(212) 410-5004
21 E 87Th St
New York, NY
Robert Moraru
(212) 732-2777
111 Broadway # 800
New York, NY
Rhonda L Karol
(516) 569-3818
545 Central Ave
Cedarhurst, NY
Data Provided by:
  

Provided By:

MONDAY, Aug. 31 (HealthDay News) -- Scientists have isolated a group of genetic mutations involved in the growth of melanoma, the deadliest form of skin cancer. Their work may lead to therapies with existing drugs that target the same mutations.

Led by Yardena Samuels of the National Human Genome Research Institute, the research team from the U.S. National Institutes of Health (NIH) sequenced the protein tyrosine kinase (PTK) gene family in tumor and blood samples from people with metastatic melanoma. Their study is published in the September issue of the journal Nature Genetics.

"We have found what appears to be an Achilles' heel of a sizable share of melanomas," Samuels, an investigator in the cancer genetics branch of the institute's Division of Intramural Research, said in a NIH news release.

The PTK family includes many genes that, when mutated, promote many types of cancer, including brain, gastric and lung malignancies, according to background information provided in the news release. In the new NIH study, one PTK gene that appeared particularly suspicious was the ERBB4 gene. Scientists found ERBB4 mutations in 19 percent of patients' tumors, making it the most frequently mutated PTK gene in melanoma. Additional lab studies found that melanoma cells with the ERBB4 defect were dependent on the mutant gene for their growth.

The researchers also found that two additional PTK genes -- FLT1 and PTK2B -- were mutated in about 10 percent of the tumor samples.

The discoveries could open up new avenues for therapies. For example, the researchers discovered that melanoma cells grew much more slowly when exposed to lapatinib (Tykerb), a chemotherapy drug that inhibits ERBB4. Lapatinib is already in use by some breast cancer patients. The NIH team is planning a clinical trial using lapatinib in patients with metastatic melanoma harboring ERBB4 mutations.

"Though additional work is needed to gain a more complete understanding of these genetic mutations and their roles in cancer biology, our findings open the door to pursuing specific therapies that may prove useful for the treatment of melanoma with ERBB4 mutations," Samuels stated.

More information

The American Cancer Society has more on melanoma.

SOURCE: U.S. National Institutes of Health, news release, Aug. 30, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Filling in Wrinkles with Dermal Fillers Flushing NY
In the summer, there are many different things that people like to do in order to have fun. Some people like to enjoy outdoor activities such as sports, while other people like to lie out in the sun for long periods of time and tan. Tanning is something that has become more and more popular amongst people since the early twentieth century, but too much tanning can lead to things like skin cancer and premature wrinkles.
- Follow Up After Skin Cancer Flushing NY
- Getting a Botox Cosmetic Injection Flushing NY
- High Levels of Selenium Decreases Incidence of Skin Cancer. Flushing NY
- Risks for Childhood Cancer Survivors Flushing NY
- Risk Factors for Squamous Cell Cancer of the Skin Flushing NY
- Breast Cancer Treatment Flushing NY
- Gene Mutation in Dogs Flushing NY
- Delayed Prostate Cancer Therapy Flushing NY
- Healing Facial Spider Veins Flushing NY